Biodexa Pharmaceuticals Plc (BDRX)
1.04
+0.43
(+69.38%)
USD |
NASDAQ |
Apr 02, 11:13
Biodexa Pharmaceuticals Research and Development Expense (TTM) : 5.234M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NuCana Plc | 16.89M |
| Mereo BioPharma Group Plc | 17.81M |
| Bicycle Therapeutics Plc | 275.99M |
| Autolus Therapeutics Plc | 117.80M |
| GSK Plc | 9.632B |